Clinical
RSSArticles
-
Bezlotoxumab Injection (Zinplava)
Bezlotoxumab neutralizes the effect of toxin B and reduces the rate of recurrence of C. difficile infection.
-
Is Yoga Effective for Treating Asthma?
Although the data on yoga in asthma are only of moderate quality, they suggest that yoga may improve quality of life and asthma symptoms.
-
What Influences ICU Admission?
High ICU utilization hospitals were more likely to use invasive procedures and incurred higher costs than low ICU utilization hospitals with no difference in mortality.
-
Is Anxiety a Risk Factor for Cardiovascular Disease?
Anxiety disorders are associated with an elevated risk of a range of different cardiovascular events including stroke, coronary heart disease, heart failure, and cardiovascular deaths, but it is unclear whether these disorders are causal in nature.
-
Just Two HPV Shots Recommended for Younger Teens
The CDC now recommends that 11- to 12-year-olds receive two doses of HPV vaccine at least six months apart, rather than the previously recommended three doses.
-
Link Between Early Menopause, Higher Risk of Fracture Confirmed
A new analysis of data from the Women’s Health Initiative trial indicates an increased risk of fracture among women who reported early menopause (age 40 or younger), regardless of whether they were treated with hormone therapy and/or calcium and vitamin D supplementation.
-
Data Indicate Male Birth Control Shot May Be Effective
Men may be able to use birth control shots to prevent pregnancy in their female partners, data suggest in a just-published Phase II study.
-
Check Reproductive Health Considerations for Women Presenting with Rheumatoid Arthritis
Women diagnosed with rheumatoid arthritis must consider their drug treatment when choosing a contraceptive. Current treatment practice is to prescribe non-biologic disease-modifying antirheumatic drugs, which reduce disease activity and prevent joint deformity, within three months of diagnosis.
-
Data Support Five-year Use of Liletta
Data from a recent analysis of the 52 mg levonorgestrel Liletta intrauterine device indicate its calculated levonorgestrel content and release rate curves support the continued evaluation of its contraceptive use for five or more years.
-
STDs at Unprecedented High in United States
Public health agencies battle rise in midst of budget cuts.